Zinkernagel RM - Search Results

1

Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.

Speiser DE, Kyburz D, Stübi U, Hengartner H, Zinkernagel RM. Speiser DE, et al. Among authors: zinkernagel rm. J Immunol. 1992 Aug 1;149(3):972-80. J Immunol. 1992. PMID: 1634779

2

Virally induced immunosuppression.

Zinkernagel RM, Hengartner H. Zinkernagel RM, et al. Curr Opin Immunol. 1992 Aug;4(4):408-12. doi: 10.1016/s0952-7915(06)80031-2. Curr Opin Immunol. 1992. PMID: 1388842 Review.

3

Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny.

Speiser DE, Pircher H, Ohashi PS, Kyburz D, Hengartner H, Zinkernagel RM. Speiser DE, et al. Among authors: zinkernagel rm. J Exp Med. 1992 May 1;175(5):1277-83. doi: 10.1084/jem.175.5.1277. J Exp Med. 1992. PMID: 1533241 Free PMC article.

4

Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo.

Moskophidis D, Pircher H, Ciernik I, Odermatt B, Hengartner H, Zinkernagel RM. Moskophidis D, et al. Among authors: zinkernagel rm. J Virol. 1992 Jun;66(6):3661-8. doi: 10.1128/JVI.66.6.3661-3668.1992. J Virol. 1992. PMID: 1583725 Free PMC article.

5

Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.

Aichele P, Hengartner H, Zinkernagel RM, Schulz M. Aichele P, et al. Among authors: zinkernagel rm. J Exp Med. 1990 May 1;171(5):1815-20. doi: 10.1084/jem.171.5.1815. J Exp Med. 1990. PMID: 1692084 Free PMC article.

6

Neonatal tolerance to MIs-1a determinants: deletion or anergy of V beta 6+ T lymphocytes depending upon MHC compatibility of neonatally injected cells.

Speiser DE, Brändle R, Lees RK, Schneider R, Zinkernagel RM, MacDonald HR. Speiser DE, et al. Among authors: zinkernagel rm. Int Immunol. 1991 Feb;3(2):127-34. doi: 10.1093/intimm/3.2.127. Int Immunol. 1991. PMID: 1709047

7

Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide.

Schulz M, Aichele P, Schneider R, Hansen TH, Zinkernagel RM, Hengartner H. Schulz M, et al. Among authors: zinkernagel rm. Eur J Immunol. 1991 May;21(5):1181-5. doi: 10.1002/eji.1830210513. Eur J Immunol. 1991. PMID: 1709866

8

Lower receptor avidity required for thymic clonal deletion than for effector T-cell function.

Pircher H, Rohrer UH, Moskophidis D, Zinkernagel RM, Hengartner H. Pircher H, et al. Among authors: zinkernagel rm. Nature. 1991 Jun 6;351(6326):482-5. doi: 10.1038/351482a0. Nature. 1991. PMID: 1710780

9

Peptide-induced antiviral protection by cytotoxic T cells.

Schulz M, Zinkernagel RM, Hengartner H. Schulz M, et al. Among authors: zinkernagel rm. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):991-3. doi: 10.1073/pnas.88.3.991. Proc Natl Acad Sci U S A. 1991. PMID: 1992491 Free PMC article.

10

Thymic MHC class I gene regulation of susceptibility to lymphocytic choriomeningitis.

Speiser DE, Zinkernagel RM. Speiser DE, et al. Among authors: zinkernagel rm. Thymus. 1990 Nov-Dec;16(3-4):187-93. Thymus. 1990. PMID: 2293422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

552 results

Search Page

Filters